Skip to main content
NCBI home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1998 Oct;51(5):277–281. doi: 10.1136/mp.51.5.277

Molecular detection of acute lymphoblastic leukaemia in boys with testicular relapse.

A Lal 1, E Kwan 1, M al Mahr 1, L Zhou 1, D Ferrara 1, V Tobias 1, D O'Gorman Hughes 1, M Haber 1, M D Norris 1, G M Marshall 1
PMCID: PMC395652  PMID: 10193523

Abstract

AIMS: To determine the role of polymerase chain reaction (PCR) based minimal residual disease (MRD) detection of leukaemia specific DNA in testicular relapse in childhood acute lymphoblastic leukaemia. METHODS: DNA was obtained from archival testicular and bone marrow samples from boys with acute lymphoblastic leukaemia who relapsed in the testes. Overlapping DJH clone specific primers derived from clonal immunoglobulin heavy chain (IgH) gene rearrangement in each case were used to analyse testicular or bone marrow DNA. RESULTS: Histologically normal end of treatment testicular biopsies in the five patients in longterm remission were all MRD negative, but MRD positive in three of six boys with subsequent testicular relapse. Histologically normal bone marrow samples taken at the end of treatment were MRD negative in five of seven cases, but MRD positive in all cases at the time of isolated testicular relapse. Three boys with unilateral testicular relapse underwent unilateral orchidectomy, rather than bilateral testicular irradiation, as part of their treatment. Two of these boys were MRD positive in the histologically uninvolved testes, and both had subsequent relapses either in the testes or the bone marrow, while the MRD negative patient has not had a testicular relapse. CONCLUSIONS: The presence of MRD in testicular tissue can be assayed with a PCR based method to detect clone specific antigen receptor gene rearrangements. In this setting, PCR is more sensitive than conventional testicular histology for predicting clinical outcomes. MRD assays might be useful in the management of boys at the time of isolated testicular relapse, to confirm the presence of unilateral testicular disease.

Full Text

The Full Text of this article is available as a PDF (188.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blatt J., Sherins R. J., Niebrugge D., Bleyer W. A., Poplack D. G. Leydig cell function in boys following treatment for testicular relapse of acute lymphoblastic leukemia. J Clin Oncol. 1985 Sep;3(9):1227–1231. doi: 10.1200/JCO.1985.3.9.1227. [DOI] [PubMed] [Google Scholar]
  2. Brisco M. J., Condon J., Hughes E., Neoh S. H., Sykes P. J., Seshadri R., Toogood I., Waters K., Tauro G., Ekert H. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet. 1994 Jan 22;343(8891):196–200. doi: 10.1016/s0140-6736(94)90988-1. [DOI] [PubMed] [Google Scholar]
  3. Carpenter P. A., Marshall G. M., Giri N., Vowels M. R., Russell S. J. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan. Bone Marrow Transplant. 1996 Sep;18(3):489–494. [PubMed] [Google Scholar]
  4. Cavé H., Guidal C., Rohrlich P., Delfau M. H., Broyart A., Lescoeur B., Rahimy C., Fenneteau O., Monplaisir N., d'Auriol L. Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. Blood. 1994 Apr 1;83(7):1892–1902. [PubMed] [Google Scholar]
  5. Chessells J. M., Bailey C., Richards S. M. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet. 1995 Jan 21;345(8943):143–148. doi: 10.1016/s0140-6736(95)90164-7. [DOI] [PubMed] [Google Scholar]
  6. Chessells J. M., Pincott J. R., Daniels-Lake W. Terminal transferase positive cells in testicular biopsy specimens from boys with acute lymphoblastic leukaemia. J Clin Pathol. 1986 Nov;39(11):1236–1240. doi: 10.1136/jcp.39.11.1236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Goulden N., Langlands K., Steward C., Katz F., Potter M., Chessells J., Oakhill A. PCR assessment of bone marrow status in 'isolated' extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia. Br J Haematol. 1994 Jun;87(2):282–285. doi: 10.1111/j.1365-2141.1994.tb04910.x. [DOI] [PubMed] [Google Scholar]
  8. Grundy R. G., Leiper A. D., Stanhope R., Chessells J. M. Survival and endocrine outcome after testicular relapse in acute lymphoblastic leukaemia. Arch Dis Child. 1997 Mar;76(3):190–196. doi: 10.1136/adc.76.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Grünewald K., Lyons J., Hansen-Hagge T. E., Janssen J. W., Feichtinger H., Bartram C. R. Molecular genetic analysis of DNA obtained from fixed, air dried or paraffin embedded sources. Ann Hematol. 1991 Apr;62(4):108–114. doi: 10.1007/BF01702923. [DOI] [PubMed] [Google Scholar]
  10. Ito Y., Wasserman R., Galili N., Reichard B. A., Shane S., Lange B., Rovera G. Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia. J Clin Oncol. 1993 Mar;11(3):546–553. doi: 10.1200/JCO.1993.11.3.546. [DOI] [PubMed] [Google Scholar]
  11. Marshall G. M., Kwan E., Haber M., Brisco M. J., Sykes P. J., Morley A. A., Toogood I., Waters K., Tauro G., Ekert H. Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia. Leukemia. 1995 Nov;9(11):1847–1850. [PubMed] [Google Scholar]
  12. Miller D. R., Leikin S. L., Albo V. C., Palmer N. F., Sather H. N., Hammond G. D. The prognostic value of testicular biopsy in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J Clin Oncol. 1990 Jan;8(1):57–66. doi: 10.1200/JCO.1990.8.1.57. [DOI] [PubMed] [Google Scholar]
  13. Nachman J., Palmer N. F., Sather H. N., Bleyer W. A., Coccia P. F., Lukens J. N., Siegel S. E., Hammond G. D. Open-wedge testicular biopsy in childhood acute lymphoblastic leukemia after two years of maintenance therapy: diagnostic accuracy and influence on outcome--a report from Children's Cancer Study Group. Blood. 1990 Mar 1;75(5):1051–1055. [PubMed] [Google Scholar]
  14. Neale G. A., Pui C. H., Mahmoud H. H., Mirro J., Jr, Crist W. M., Rivera G. K., Goorha R. M. Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia. Leukemia. 1994 May;8(5):768–775. [PubMed] [Google Scholar]
  15. Norris M. D., Kwan E., Haber M., Marshall G. M. Detection of evolving immunoglobulin heavy-chain gene rearrangements in acute lymphoblastic leukemia: a PCR-based assay employing overlapping DJH primers. Leukemia. 1995 Oct;9(10):1779–1782. [PubMed] [Google Scholar]
  16. O'Reilly J., Meyer B., Baker D., Herrmann R., Cannell P., Davies J. Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemia. Leukemia. 1995 Apr;9(4):624–627. [PubMed] [Google Scholar]
  17. Reiter A., Schrappe M., Ludwig W. D., Hiddemann W., Sauter S., Henze G., Zimmermann M., Lampert F., Havers W., Niethammer D. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood. 1994 Nov 1;84(9):3122–3133. [PubMed] [Google Scholar]
  18. Roberts W. M., Estrov Z., Ouspenskaia M. V., Johnston D. A., McClain K. L., Zipf T. F. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med. 1997 Jan 30;336(5):317–323. doi: 10.1056/NEJM199701303360501. [DOI] [PubMed] [Google Scholar]
  19. Steward C. G., Goulden N. J., Katz F., Baines D., Martin P. G., Langlands K., Potter M. N., Chessells J. M., Oakhill A. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood. 1994 Mar 1;83(5):1355–1362. [PubMed] [Google Scholar]
  20. Wofford M. M., Smith S. D., Shuster J. J., Johnson W., Buchanan G. R., Wharam M. D., Ritchey A. K., Rosen D., Haggard M. E., Golembe B. L. Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol. 1992 Apr;10(4):624–630. doi: 10.1200/JCO.1992.10.4.624. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES